Research progress in the development of direct acting antiviral agents for hepatitis C and the anti-viral resistance
Lists
Only you see this
Abstract
Recently,directly acting antiviral agents against hepatitic C virus with different mechanisms have been developed and put into clinical trials.Especially,results of phase Ⅲ clinical trials of Boceprevir and Telaprevir have been published,and these two agents are to be approved for marketing in recent years.Also much attention has been paid on anti-viral resistance against direct acting antiviral agents.Great progresses have been made in field of direct acting antiviral agents against hepatitic C virus.Domestic studies in this area should take characteristics of virus and host of Chinese chronic hepatitis C into consideration.
BibTeX
@inproceedings{yang2011research,
author = {Song Yang and Jun Cheng},
title = {{Research progress in the development of direct acting antiviral agents for hepatitis C and the anti-viral resistance}},
booktitle = {SHILAP},
year = {2011},
}Loading related content...